<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35504537</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1995-820X</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Virologica Sinica</Title><ISOAbbreviation>Virol Sin</ISOAbbreviation></Journal><ArticleTitle>EV71 3C protease cleaves host anti-viral factor OAS3 and enhances virus replication.</ArticleTitle><Pagination><StartPage>418</StartPage><EndPage>426</EndPage><MedlinePgn>418-426</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virs.2022.04.013</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1995-820X(22)00077-3</ELocationID><Abstract><AbstractText>The global spread of enteroviruses (EVs) has become more frequent, severe and life-threatening. Intereron (IFN) I has been proved to control EVs by regulating IFN-stimulated genes (ISG) expression. 2'-5'-oligoadenylate synthetases 3 (OAS3) is an important ISG in the OAS/RNase L antiviral system. The relationship between OAS3 and EVs is still unclear. Here, we reveal that OAS3, superior to OAS1 and OAS2, significantly inhibited EV71 replication in vitro. However, EV71 utilized autologous 3C protease (3C<sup>pro</sup>) to cleave intracellular OAS3 and enhance viral replication. Rupintrivir, a human rhinovirus 3C protease inhibitor, completely abolished the cleavage of EV71 3C<sup>pro</sup> on OAS3. And the proteolytically deficient mutants H40G, E71A, and C147G of EV71 3C<sup>pro</sup> also lost the ability of OAS3 cleavage. Mechanistically, the Q982-G983 motif in C-terminal of OAS3 was identified as a crucial 3C<sup>pro</sup> cutting site. Further investigation indicated that OAS3 inhibited not only EV71 but also Coxsackievirus B3 (CVB3), Coxsackievirus A16 (CA16), Enterovirus D68 (EVD68), and Coxsackievirus A6 (CA6) subtypes. Notably, unlike other four subtypes, CA16 3C<sup>pro</sup> could not cleave OAS3. Two key amino acids variation Ile36 and Val86 in CA16 3C<sup>pro</sup> might result in weak and delayed virus replication of CA16 because of failure of OAS and 3AB cleavage. Our works elucidate the broad anti-EVs function of OAS3, and illuminate a novel mechanism by which EV71 use 3C<sup>pro</sup> to escape the antiviral effect of OAS3. These findings can be an important entry point for developing novel therapeutic strategies for multiple EVs infection.</AbstractText><CopyrightInformation>Copyright © 2022 The Authors. Publishing services by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Xiaolei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Center for Infectious Diseases and Pathogen Biology, Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, The First Hospital of Jilin University, Jilin, 130021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for Infectious Diseases and Pathogen Biology, Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, The First Hospital of Jilin University, Jilin, 130021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Infectious Diseases and Pathogen Biology, Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, The First Hospital of Jilin University, Jilin, 130021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Baisong</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Center for Infectious Diseases and Pathogen Biology, Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, The First Hospital of Jilin University, Jilin, 130021, China. Electronic address: zhengbs@jlu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wenyan</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center for Infectious Diseases and Pathogen Biology, Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, The First Hospital of Jilin University, Jilin, 130021, China. Electronic address: zhangwenyan@jlu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Virol Sin</MedlineTA><NlmUniqueID>101514185</NlmUniqueID><ISSNLinking>1995-820X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000227">Adenine Nucleotides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009843">Oligoribonucleotides</NameOfSubstance></Chemical><Chemical><RegistryNumber>61172-40-5</RegistryNumber><NameOfSubstance UI="C023505">2',5'-oligoadenylate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.84</RegistryNumber><NameOfSubstance UI="D015088">2',5'-Oligoadenylate Synthetase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.84</RegistryNumber><NameOfSubstance UI="C577439">OAS3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010447">Peptide Hydrolases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.28</RegistryNumber><NameOfSubstance UI="D000086042">3C Viral Proteases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 6.-</RegistryNumber><NameOfSubstance UI="D008025">Ligases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015088" MajorTopicYN="N">2',5'-Oligoadenylate Synthetase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086042" MajorTopicYN="N">3C Viral Proteases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000227" MajorTopicYN="N">Adenine Nucleotides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008025" MajorTopicYN="N">Ligases</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009843" MajorTopicYN="N">Oligoribonucleotides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010447" MajorTopicYN="N">Peptide Hydrolases</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">3C protease</Keyword><Keyword MajorTopicYN="N">Anti-viral factor</Keyword><Keyword MajorTopicYN="N">Cleavage</Keyword><Keyword MajorTopicYN="N">EV71</Keyword><Keyword MajorTopicYN="N">Enteroviruses</Keyword><Keyword MajorTopicYN="N">OAS3</Keyword></KeywordList><CoiStatement>Conflict of interest The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>3</Day><Hour>19</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35504537</ArticleId><ArticleId IdType="pmc">PMC9243667</ArticleId><ArticleId IdType="doi">10.1016/j.virs.2022.04.013</ArticleId><ArticleId IdType="pii">S1995-820X(22)00077-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baggen J., Thibaut H.J., Strating J., van Kuppeveld F.J.M. The life cycle of non-polio enteroviruses and how to target it. Nat. Rev. Microbiol. 2018;16:368–381.</Citation><ArticleIdList><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang H.W., Watson J.C., Jacobs B.L. The e3l gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc. Natl. Acad. Sci. Unit. States Am. 1992;89:4825–4829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC49180</ArticleId><ArticleId IdType="pubmed">1350676</ArticleId></ArticleIdList></Reference><Reference><Citation>Coccia E.M., Romeo G., Nissim A., Marziali G., Albertini R., Affabris E., Battistini A., Fiorucci G., Orsatti R., Rossi G.B., et al. A full-length murine 2-5a synthetase cdna transfected in nih-3t3 cells impairs emcv but not vsv replication. Virology. 1990;179:228–233.</Citation><ArticleIdList><ArticleId IdType="pubmed">2171206</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh A., Sarkar S.N., Sen G.C. Cell growth regulatory and antiviral effects of the p69 isozyme of 2-5 (a) synthetase. Virology. 2000;266:319–328.</Citation><ArticleIdList><ArticleId IdType="pubmed">10639318</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J.Q., Townsend H.L., Jha B.K., Paranjape J.M., Silverman R.H., Barton D.J. A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease Rnase l. J. Virol. 2007;81:5561–5572.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1900262</ArticleId><ArticleId IdType="pubmed">17344297</ArticleId></ArticleIdList></Reference><Reference><Citation>Hovanessian A.G., Justesen J. The human 2'-5'oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2'-5' instead of 3'-5' phosphodiester bond formation. Biochimie. 2007;89:779–788.</Citation><ArticleIdList><ArticleId IdType="pubmed">17408844</ArticleId></ArticleIdList></Reference><Reference><Citation>Huismans H., Joklik W.K. Reovirus-coded polypeptides in infected cells: isolation of two native monomeric polypeptides with affinity for single-stranded and double-stranded RNA, respectively. Virology. 1976;70:411–424.</Citation><ArticleIdList><ArticleId IdType="pubmed">1266045</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibsen M.S., Gad H.H., Andersen L.L., Hornung V., Julkunen I., Sarkar S.N., Hartmann R. Structural and functional analysis reveals that human OASL binds dsRNA to enhance RIG-I signaling. Nucleic Acids Res. 2015;43:5236–5248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4446440</ArticleId><ArticleId IdType="pubmed">25925578</ArticleId></ArticleIdList></Reference><Reference><Citation>Justesen J., Hartmann R., Kjeldgaard N.O. Gene structure and function of the 2'-5'-oligoadenylate synthetase family. Cell. Mol. Life Sci. 2000;57:1593–1612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11146851</ArticleId><ArticleId IdType="pubmed">11092454</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura N., Semler B.L., Rothberg P.G., Larsen G.R., Adler C.J., Dorner A.J., Emini E.A., Hanecak R., Lee J.J., van der Werf S., Anderson C.W., Wimmer E. Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature. 1981;291:547–553.</Citation><ArticleIdList><ArticleId IdType="pubmed">6264310</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristiansen H., Gad H.H., Eskildsen-Larsen S., Despres P., Hartmann R. The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities. J. Interferon Cytokine Res. 2011;31:41–47.</Citation><ArticleIdList><ArticleId IdType="pubmed">21142819</ArticleId></ArticleIdList></Reference><Reference><Citation>Laitinen O.H., Svedin E., Kapell S., Nurminen A., Hytönen V.P., Flodström-Tullberg M. Enteroviral proteases: structure, host interactions and pathogenicity. Rev. Med. Virol. 2016;26:251–267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7169145</ArticleId><ArticleId IdType="pubmed">27145174</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Xiao X., Xue Q., Jin Q., He B., Wang J. Cleavage of interferon regulatory factor 7 by enterovirus 71 3c suppresses cellular responses. J. Virol. 2013;87:1690–1698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3554134</ArticleId><ArticleId IdType="pubmed">23175366</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Zhang Z., Xiao X., Qi J., He B., Wang J. Enterovirus 71 inhibits pyroptosis through cleavage of gasdermin d. J. Virol. 2017;91</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5571240</ArticleId><ArticleId IdType="pubmed">28679757</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J.Y., Chen T.C., Weng K.F., Chang S.C., Chen L.L., Shih S.R. Viral and host proteins involved in picornavirus life cycle. J. Biomed. Sci. 2009;16:103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2785775</ArticleId><ArticleId IdType="pubmed">19925687</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Liu P., Liu S., Guo Y., He H., Yang C., Song J., Zhang N., Cheng J., Chen Z. Oligoadenylate synthetase 3 s381r gene polymorphism is associated with severity of ev71 infection in Chinese children. J. Clin. Virol. 2018;101:29–33.</Citation><ArticleIdList><ArticleId IdType="pubmed">29414184</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J., Yi L., Zhao J., Yu J., Chen Y., Lin M.C., Kung H.F., He M.L. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J. Virol. 2012;86:3767–3776.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J., Yi L., Ke C., Zhang Y., Liu R., Chen J., Kung H.F., He M.L. The interaction between human enteroviruses and type I IFN signaling pathway. Crit. Rev. Microbiol. 2015;41:201–207.</Citation><ArticleIdList><ArticleId IdType="pubmed">23919297</ArticleId></ArticleIdList></Reference><Reference><Citation>Min J.-Y., Krug R.M. The primary function of RNA binding by the influenza A virus ns1 protein in infected cells: inhibiting the 2′-5′ oligo (a) synthetase/RNAse l pathway. Proc. Natl. Acad. Sci. Unit. States Am. 2006;103:7100–7105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1459024</ArticleId><ArticleId IdType="pubmed">16627618</ArticleId></ArticleIdList></Reference><Reference><Citation>Muehlenbachs A., Bhatnagar J., Zaki S.R. Tissue tropism, pathology and pathogenesis of enterovirus infection. J. Pathol. 2015;235:217–228.</Citation><ArticleIdList><ArticleId IdType="pubmed">25211036</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollack A., Kontorovich A.R., Fuster V., Dec G.W. Viral myocarditis--diagnosis, treatment options, and current controversies. Nat. Rev. Cardiol. 2015;12:670–680.</Citation><ArticleIdList><ArticleId IdType="pubmed">26194549</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Salort M., Parker E.P., Grassly N.C. The epidemiology of non-polio enteroviruses: recent advances and outstanding questions. Curr. Opin. Infect. Dis. 2015;28:479–487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6624138</ArticleId><ArticleId IdType="pubmed">26203854</ArticleId></ArticleIdList></Reference><Reference><Citation>Rysiecki G., Gewert D.R., Williams B.R. Constitutive expression of a 2',5'-oligoadenylate synthetase cdna results in increased antiviral activity and growth suppression. J. Interferon Res. 1989;9:649–657.</Citation><ArticleIdList><ArticleId IdType="pubmed">2481699</ArticleId></ArticleIdList></Reference><Reference><Citation>Schröder H.C., Ugarković D., Wenger R., Reuter P., Okamoto T., Müller W.E. Binding of tat protein to tar region of human immunodeficiency virus type 1 blocks tar-mediated activation of (2'-5')oligoadenylate synthetase. AIDS Res. Hum. Retrovir. 1990;6:659–672.</Citation><ArticleIdList><ArticleId IdType="pubmed">1694453</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman R.H. Viral encounters with 2’,5’-oligoadenylate synthetase and RNase l during the interferon antiviral response. J. Virol. 2007;81:12720–12729.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2169107</ArticleId><ArticleId IdType="pubmed">17804500</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T., Lewthwaite P., Perera D., Cardosa M.J., McMinn P., Ooi M.H. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 2010;10:778–790.</Citation><ArticleIdList><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Y., Yang T., Liu P., Chen L., Tian Q., Guo Y., He H., Liu Y., Chen Z. Association of the oas3 rs1859330 g/a genetic polymorphism with severity of enterovirus-71 infection in Chinese han children. Arch. Virol. 2017;162:2305–2313.</Citation><ArticleIdList><ArticleId IdType="pubmed">28444539</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Fan T., Yao X., Wu Z., Guo L., Lei X., Wang J., Wang M., Jin Q., Cui S. Crystal structures of enterovirus 71 3c protease complexed with rupintrivir reveal the roles of catalytically important residues. J. Virol. 2011;85:10021–10030.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196404</ArticleId><ArticleId IdType="pubmed">21813612</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng K.F., Li M.L., Hung C.T., Shih S.R. Enterovirus 71 3c protease cleaves a novel target cstf-64 and inhibits cellular polyadenylation. PLoS Pathog. 2009;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2742901</ArticleId><ArticleId IdType="pubmed">19779565</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu N., Yang J., Zheng B., Zhang Y., Cao Y., Huan C., Wang S., Chang J., Zhang W. The pyrimidine analog fnc potently inhibits the replication of multiple enteroviruses. J. Virol. 2020;94</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7163137</ArticleId><ArticleId IdType="pubmed">32075935</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R., Jha B.K., Ogden K.M., Dong B., Zhao L., Elliott R., Patton J.T., Silverman R.H., Weiss S.R. Homologous 2′,5′-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity. Proc. Natl. Acad. Sci. Unit. States Am. 2013;110:13114–13119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3740845</ArticleId><ArticleId IdType="pubmed">23878220</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L., Jha Babal K., Wu A., Elliott R., Ziebuhr J., Gorbalenya Alexander E., Silverman Robert H., Weiss Susan R. Antagonism of the interferon-induced oas-RNase l pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology. Cell Host Microbe. 2012;11:607–616.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3377938</ArticleId><ArticleId IdType="pubmed">22704621</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou A., Hassel B.A., Silverman R.H. Expression cloning of 2-5a-dependent RNAase: a uniquely regulated mediator of interferon action. Cell. 1993;72:753–765.</Citation><ArticleIdList><ArticleId IdType="pubmed">7680958</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>